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Background: Crohn’s disease (CD) is an immune-related disease with genetic predisposition. This study aimed to
investigate the association of three polymorphisms in the signal transducer and activator of transcription 3 (STAT3)
gene with CD risk in a Chinese population.
Methods: We conducted a hospital-based case–control study involving 232 CD patients and 272 controls. Genotyping
was performed using polymerase chain reaction with sequence-specific primer method. Statistical analyses were
conducted using logistic regression and genotype risk scoring.
Results: Significant differences were found between patients and controls in allele/genotype distributions of rs744166
(Pallele = 0.0008; Pgenotype = 0.003) and allele distributions of rs4796793 (P = 0.03). The risk for CD associated with the
rs744166-A mutant allele decreased by 37% [95% confidence interval (CI): 0.48–0.83] under the additive model, 39%
(95% CI: 0.43–0.81) under the dominant model and 57% (95% CI: 0.24–0.77) under the recessive model. Carriers of the
rs4796793-G mutant allele exhibited 25% (95% CI: 0.58–0.98; P = 0.03) and 47% (95% CI: 0.30–0.95) decreased risks of
developing CD under the additive and recessive models, respectively.
Conclusions: STAT3 rs744166 and rs4796793 polymorphisms may be associated with CD occurrence and used as a
predictive factor of CD in Chinese Han populations.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
2169674321122294
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Crohn’s disease (CD) and ulcerative colitis (UC) are
inflammatory bowel diseases (IBDs). The etiology and
pathogenesis of CD are not completely understood. How-
ever, familial aggregation and twin studies report that
patients with CD carry strong genetic predisposition [1].
Several studies also strongly suggest that CD results from
a combination of factors, such as commensal bacteria,
food antigens, immunologic factors and multiple genetic
factors [2,3]. The signal transducer and activator of tran-
scription 3 (STAT3) gene is a potential candidate gene for* Correspondence: Jimmyzj64@medmail.com.cn
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unless otherwise stated.CD for several reasons. STAT3 is a member of STAT
family, which possesses an important function in the
development of human immune system and haemato-
poiesis. This gene has been associated with the signal
transduction pathway of multiple cytokines, including
IL-2/γc, IL-6/gp130, IFN and IL-10 families, as well as
IL-12, IL- 23, Flt3 ligand, M-CSF, G-CSF, leptin and
growth hormone [4-9]. Several studies have highlighted
that the STAT3 signaling pathway is important in the
occurrence and development of IBD both in patients
and animal models [10-13].
In 2008, Barrett et al. [14] reported that the STAT3
locus is significantly associated with CD susceptibility in
a genome-wide association study (GWAS). Since then, a
number of studies have demonstrated that the polymor-
phisms of STAT3 are associated with CD as well as UC,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion cohorts [15-20]. Therefore, we performed an ana-
lysis on three polymorphisms (rs2293152, rs4796793 and
rs744166) of STAT3 and CD in Chinese Han population.
Methods
Patient and control subjects
This hospital-based case–control study involved 232 CD
patients and 272 healthy controls of Chinese Han popu-
lation recruited from the Department of Gastroenterology
of Ruijin Hospital, which is connected with the Shanghai
Jiaotong University School of Medicine between January
2009 and December 2010. Senior physicians diagnosed all
patients based on clinical, endoscopic, radiological and
histopathological findings in accordance with previously
established international criteria [21]. All patients were
followed up at least for 1 year and registered with an inte-
grated clinical and epidemiological registry. Controls were
randomly selected from healthy persons under routine
health screening. The present study was performed in
accordance with the principles of Declaration of Helsinki
and approved by the Research Ethics Committee of Ruijin
Hospital, Shanghai, China. Informed consent was obtained
from all subjects before blood sampling was carried out.
Genotyping
Genomic DNA was isolated from Ethylene Diamine Tetra-
acetic Acid (EDTA) peripheral blood using the QIAamp
blood extraction kit (Qiagen, Hilden, Germany) follow-
ing the manufacturer’s instructions. All DNA samples
were genotyped for single nucleotide polymorphisms
by polymerase chain reaction with sequence-specific
primers (PCR-SSPs). All primers for the PCR-SSPs were
designed using the genomic sequences in GenBank (http://
www.ncbi.nlm.nih.gov). The primer sequences are listed
in Table 1. The amplified products were assessed for the
presence/absence of PCR amplicons specific to particularTable 1 The primer sequence used for genotyping








Internal control forward primer
Common reverse primer
Specific primer C
Specific primer Galleles using a standard 2% agarose gel electrophoresis,
followed by ethidium-bromide staining. About 10% of the
samples were then confirmed by sequencing.
Statistical analysis
For continuous and categorical variables, unpaired t-test
and χ2 were conducted to compare CD patients and
controls, respectively. To avoid gross genotyping error,
all polymorphisms were evaluated for consistency with
Hardy–Weinberg equilibrium on a contingency table of
observed-versus-predicted genotype frequencies by using
Pearson χ2 test or Fisher's exact test. Genotypes were
compared by logistic regression analysis under assump-
tions of additive, dominant and recessive models of inher-
itance. A P < 0.05 was considered statistically significant.
Results
Table 2 shows detailed information of patients and con-
trols. Cases and controls were well matched by age and
gender distribution.
The frequencies and distributions of alleles and geno-
types at rs2293152, rs4796793 and rs744166 STAT3 were
identified and compared between CD patients and con-
trols. The genotype distributions of the three polymor-
phisms of STAT3 were in Hardy–Weinberg equilibrium
in control groups (P > 0.05).
Table 3 shows that a significant difference was observed
for rs744166 between CD patients and controls both in
allele and genotype distributions (Pallele = 0.0008, and
Pgenotype = 0.003). A significant decreased risk was iden-
tified for rs744166 in association with CD under the
additive [odds ratio (OR) = 0.63; 95% confidence interval
(CI): 0.48–0.83], dominant (OR = 0.61; 95% CI: 0.43–0.81)
and recessive (OR = 0.43; 95% CI: 0.24–0.77) models.
As for rs4796793, a significant difference was observed
between the two groups in allele but not in genotype dis-












Table 2 Characteristics of CD patients and healthy
controls in the Chinese Han population
Characteristics CD patients Control subjects
Number 232 272
Age, mean ± SD (years) 33.6 ± 13.5 46.4 ± 9.8
Age range (years) 20-70 18-70
Male /female 149/83 172/100
Smoking (%) 53 (22.84) 67 (24.63)
Drinking (%) 32 (13.79) 39 (14.34)
Appendectomy (%) 15 (6.47) 18 (6.62)
Family history of CD 0 0
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CD under the additive (OR = 0.75; 95% CI: 0.58–0.98) and
recessive (OR = 0.53; 95% CI: 0.30–0.95) models, whereas
no significant association was detected under the dominant
model (OR = 0.76; 95% CI: 0.57–1.09).
No significant difference was observed in the genotype
and allele distributions of rs2293152 between CD patients
and controls. This result also agrees under the assump-
tions of the additive (OR = 0.94; 95% CI: 0.73–1.23), dom-
inant (OR = 1.19; 95% CI: 0.80–1.77) and recessive (OR =
0.66; 95% CI: 0.42–1.05) models.
Discussion
CD is a relapsing inflammatory condition of gastrointes-
tinal mucosal damage with characteristic extra-intestinal
manifestations [22,23]. CD is widely known as an immune-
related disease with genetic predisposition. Given the
importance of immunity in CD, investigations on CD-
susceptibility genes that involve immunity have attracted
considerable attention [24,25].
The STAT3 gene is located on chromosome 17q21. Its
protein product is a member of the STAT protein family
that performs a dual function: signal transduction and
transcription activation. STAT3 is widely expressed and
a latent cytoplasmic transcription factor that relays sig-
nals from the cell membrane directly to the nucleus.
STAT3 becomes activated through phosphorylation on
tyrosine as a DNA-binding protein in response to a var-
iety of stimuli and mediates the expression of a variety
of genes. Thus, STAT3 possesses a key function in many
biological pathways crucial to cell function, including
proliferation, migration, survival and differentiation [26].
Several studies indicated that STAT3 activation plays
distinctly different roles between innate and acquired
immune responses in colitis, that is, activation of STAT3
in innate immune cells enhances mucosal barrier func-
tion and STAT3 activation in T-cells exacerbates colitis
[11,12]. A number of studies also suggest that polymor-
phisms of STAT3 are associated with the susceptibility
of CD or UC in some population cohorts [15-20].We examined three polymorphisms of STAT3 in 232
CD patients and 272 normal controls of Chinese Han
population. Results revealed that both the STAT3 gene
alleles of rs4796793G and rs744166C reduced the risk of
CD occurrence and may have a protective function in
CD. To the authors' knowledge, this is the pilot study
that explored the genetic susceptibility of STAT3 gene to
CD in a Chinese population.
The rs744166, which was first identified as an important
candidate susceptibility locus for CD in a GWAS research
[14], was confirmed in a Chinese population in this study.
Our results are in agreement with those previously
published data in a New Zealand population [17]. They
found a significant decrease in the frequency of the G
allele of rs744166 in CD patients compared with con-
trols (OR = 0.76, 95% CI = 0.61–0.95, P = 0.013), and G
allele may be protective against CD. However, Franke
et al. [15] failed to replicate the association between
rs744166 and CD risk in a German population. This dis-
crepancy may be mostly due to the heterogeneous genetic
predispositions in people of different ethnicities. The gen-
etic markers in predisposition to IBD vary across geo-
graphical and racial groups. In our previous meta-analyses,
the CD14 gene C-260 T polymorphism exhibits remark-
able heterogeneity with UC across ethnic groups, which is
significant in Asians but not in Caucasians [27]. However,
given the relatively small samples in this study, more
studies are required to reliably quantify the effect of
rs744166.
rs2293152, a STAT3 variant, has been reported to be
significantly associated with CD in Japanese population
[16]. This variant did not show significant association
between CD patient and normal control groups in this
study. Sample size may be one of the major determinants
because both studies (Sato’s research and our study)
selected East Asia population. Sato’s study only enrolled 83
CD cases and 200 healthy controls, whereas our study in-
cluded 232 CD cases and 272 normal controls. Given the
larger sample size, our result seems more reliable. We could
not exclude the different population results in different
genetic backgrounds.
In the present study, a new candidate locus, rs4796793,
was found, which was associated with CD in Chinese
population. This association is not reported in other
studies. Therefore, further studies should be carried out
to verify this association using a large sample size from
different ethnic origins and biological research.
This study has some drawbacks. First, the sample size
was not very large; thus, more SNP sites for pair-loci D'/r2
value analysis and haplotype analysis on a larger number
of Chinese subjects and on other ethnicities are neces-
sary to confirm the association more clearly. Second, we
only revealed limited polymorphisms of STAT3 gene asso-
ciated with susceptibility to CD, and other unidentified
Table 3 The genotype distributions and allele frequencies of the studied polymorphisms between patients and controls, and their risk prediction for CD under
three genetic models of inheritance
Polymorphism CD group (%) Healthy control (%) χ2 P† allele CD group (%) Healthy control (%) χ2 P‡ CD group HWe Pb Healthy control HWe Pb
rs2293152 GG 58 (25.2) 78 (28.7) G 253(55.0) 292(53.7)
CG 137 (59.6) 136(50) 5.16 0.08 C 207(45.0) 252(46.3) 0.18 0.67 0.21 0.93
CC 35 (15.2) 58 (21.3)
OR; 95% CI; P Additive model: 094; (0.73,1.23); 0.66 Dominant model: 1.19; (0.8,1.77); 0.39 Recessive model: 0.66; (0.42,1.05); 0.08
rs4796793 CC 111 (47.8) 112 (41.2) C 324 (69.8) 345 (63.4)
CG 102 (44.0) 121 (44.5) 5.38 0.07 G 140(30.2) 199 (36.6) 4.61 0.03 0.51 0.50
GG 19 (8.2) 39 (14.3)
OR; 95% CI; P Additive model: 075; (0.58,0.98); 0.03 Dominant model: 0.76; (0.57,1.09); 0.13 Recessive model: 0.53; (0.30,0.95); 0.03
rs744166 TT 106(48) 98 (36.2) T 309 (69.9) 323 (59.6)
CT 97(43.9) 127 (46.9) 11.62 0.003 C 133 (30.1) 219 (40.4) 11.28 0.0008 0.52 0.66
CC 18 (8.1) 46 (16.9)
OR; 95% CI; P Additive model: 063; (0.48,0.83); <0.001 Dominant model: 0.61; (0.43,0.81); 0.008 Recessive model: 0.43; (0.24,0.77); 0.005
Abbreviations: HWe Hardy-Weinberg equilibrium. P values were calculated using χ2 test 3 × 2 contingency table (†) for genotype distributions and 2 × 2 contingency table (‡) for allele distributions.OR, 95%CI and
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CD, may still exist. Third, our results were based on un-
adjusted estimates. STAT3 gene polymorphisms of
rs4796793 and rs744166 individually make a protective
contribution against CD, but whether the polymorphisms
integrated with other risk factors will change the predic-
tion requires additional research. Thus, a more precise
analysis should be conducted with individual data, which
would allow for the adjustment by other co-varieties, such
as age, gender, lifestyle and other genetic factors.
Conclusion
In conclusion, this study is the first to demonstrate the
single-marker association of STAT3 with CD susceptibility
in the Chinese Han population. We confirmed that STAT3
rs744166 and rs4796793 polymorphisms were associated
with CD occurrence and used as a predictive factor of CD
in Chinese Han populations.However, the diverse genetic
profiles across different ethnic groups remain unclear.
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